NO20081676L - Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika - Google Patents

Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika

Info

Publication number: NO20081676L
Authority: NO; Norway
Prior art keywords: disorders; amides; bicyclic aryl; thiadlazol; pharmaceuticals
Prior art date: 2005-10-06

Application number

NO20081676A

Other languages

English (en)

Norwegian (no)

Inventor

Stefanie Keil

Matthias Urmann

Hans Matter

Wolfgang Wendler

Maike Glien

Karl Schoenafinger

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-06

Filing date

2008-04-04

Publication date

2008-04-29

2008-04-04 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2008-04-29 Publication of NO20081676L publication Critical patent/NO20081676L/no

Links

238000000034 method Methods 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
239000002253 acid Substances 0.000 title 1
150000001408 amides Chemical class 0.000 title 1
239000003814 drug Substances 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
206010022489 Insulin Resistance Diseases 0.000 abstract 1
102000023984 PPAR alpha Human genes 0.000 abstract 1
229940080774 Peroxisome proliferator-activated receptor gamma agonist Drugs 0.000 abstract 1
-1 bicyclic aryl sulfonic acid [1,3,4] thiadiazol-2-yl amides Chemical class 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000003210 demyelinating effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000004129 fatty acid metabolism Effects 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
210000001428 peripheral nervous system Anatomy 0.000 abstract 1
108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20081676A 2005-10-06 2008-04-04 Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika NO20081676L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05021785		2005-10-06
PCT/EP2006/009300 WO2007039174A2 (fr)	2005-10-06	2006-09-26	[1,3,4]-thiadiazol-2-yl-amides bicycliques de l'acide aryl-sulfonique, leurs procedes de preparation, et leur utilisation en tant que substances pharmaceutiques

Publications (1)

Publication Number	Publication Date
NO20081676L true NO20081676L (no)	2008-04-29

Family

ID=45219048

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081676A NO20081676L (no)	2005-10-06	2008-04-04	Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika

Country Status (19)

Country	Link
US (2)	US7612104B2 (fr)
EP (1)	EP1937675B1 (fr)
JP (1)	JP2009510146A (fr)
KR (1)	KR20080050607A (fr)
CN (1)	CN101282969A (fr)
AR (1)	AR056563A1 (fr)
AT (1)	ATE513829T1 (fr)
AU (1)	AU2006299088A1 (fr)
BR (1)	BRPI0616872A2 (fr)
CA (1)	CA2624329A1 (fr)
IL (1)	IL190459A0 (fr)
MA (1)	MA29811B1 (fr)
NO (1)	NO20081676L (fr)
NZ (1)	NZ567204A (fr)
RU (1)	RU2008113209A (fr)
TW (1)	TW200811120A (fr)
UY (1)	UY29848A1 (fr)
WO (1)	WO2007039174A2 (fr)
ZA (1)	ZA200801989B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UY32443A (es)	2009-02-13	2010-09-30	Sanofi Aventis	Nuevos tetrahidronaftalenos, procesos para su preparación y uso de los mismos como medicamento.
AR075401A1 (es) *	2009-02-13	2011-03-30	Sanofi Aventis	Indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento
GB201810092D0 (en)	2018-06-20	2018-08-08	Ctxt Pty Ltd	Compounds
GB201810581D0 (en)	2018-06-28	2018-08-15	Ctxt Pty Ltd	Compounds
SI4299135T1 (sl)	2019-06-18	2025-12-31	Pfizer Inc.	Benzizoksazolni sulfonamidni derivati
CN116041230B (zh) *	2023-01-08	2024-03-19	中国海洋大学	一种nlrp3炎症小体抑制剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1670282B2 (de) *	1967-10-24	1977-02-24		Antidiabetisch wirksame hydrindensulfonylamino-pyrimidine sowie verfahren zu deren herstellung
DE2533604A1 (de) *	1975-07-26	1977-02-10	Bayer Ag	2-substituierte 5-trifluormethyl1,3,4-thiadiazole, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und insektizide
US5097669A (en) *	1991-02-11	1992-03-24	Westinghouse Electric Corp.	Control of hydrogen cooler employed in power generators
PL357678A1 (en) *	2000-04-28	2004-07-26	Sankyo Company, Limited	Ppargamma modulators
CA2531418A1 (fr) *	2003-07-08	2005-01-20	Novartis Ag	Composes benzenesulfonylamino, et compositions pharmaceutiques contenant ces composes
WO2006133459A1 (fr)	2005-06-09	2006-12-14	Vertex Pharmaceuticals Incorporated	Derives d'indane comme modulateurs de canaux ioniques

2006
- 2006-09-26 RU RU2008113209/04A patent/RU2008113209A/ru not_active Application Discontinuation
- 2006-09-26 JP JP2008533906A patent/JP2009510146A/ja not_active Abandoned
- 2006-09-26 NZ NZ567204A patent/NZ567204A/en not_active IP Right Cessation
- 2006-09-26 AT AT06792248T patent/ATE513829T1/de not_active IP Right Cessation
- 2006-09-26 EP EP06792248A patent/EP1937675B1/fr active Active
- 2006-09-26 CN CNA2006800370553A patent/CN101282969A/zh active Pending
- 2006-09-26 BR BRPI0616872-8A patent/BRPI0616872A2/pt not_active IP Right Cessation
- 2006-09-26 CA CA002624329A patent/CA2624329A1/fr not_active Abandoned
- 2006-09-26 AU AU2006299088A patent/AU2006299088A1/en not_active Abandoned
- 2006-09-26 WO PCT/EP2006/009300 patent/WO2007039174A2/fr not_active Ceased
- 2006-09-26 KR KR1020087008253A patent/KR20080050607A/ko not_active Withdrawn
- 2006-09-27 TW TW095135655A patent/TW200811120A/zh unknown
- 2006-10-04 AR ARP060104362A patent/AR056563A1/es not_active Application Discontinuation
- 2006-10-06 UY UY29848A patent/UY29848A1/es not_active Application Discontinuation
2008
- 2008-03-03 ZA ZA200801989A patent/ZA200801989B/xx unknown
- 2008-03-26 IL IL190459A patent/IL190459A0/en unknown
- 2008-03-31 MA MA30789A patent/MA29811B1/fr unknown
- 2008-04-04 US US12/062,759 patent/US7612104B2/en not_active Expired - Fee Related
- 2008-04-04 NO NO20081676A patent/NO20081676L/no not_active Application Discontinuation
2009
- 2009-09-24 US US12/566,179 patent/US7772257B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2624329A1 (fr)	2007-04-12
EP1937675B1 (fr)	2011-06-22
US7772257B2 (en)	2010-08-10
UY29848A1 (es)	2007-05-31
KR20080050607A (ko)	2008-06-09
MA29811B1 (fr)	2008-09-01
WO2007039174A3 (fr)	2007-08-09
JP2009510146A (ja)	2009-03-12
CN101282969A (zh)	2008-10-08
BRPI0616872A2 (pt)	2011-07-05
NZ567204A (en)	2010-06-25
US7612104B2 (en)	2009-11-03
WO2007039174A2 (fr)	2007-04-12
TW200811120A (en)	2008-03-01
AR056563A1 (es)	2007-10-10
RU2008113209A (ru)	2009-10-10
EP1937675A2 (fr)	2008-07-02
AU2006299088A1 (en)	2007-04-12
ZA200801989B (en)	2009-08-26
US20080293780A1 (en)	2008-11-27
IL190459A0 (en)	2008-11-03
ATE513829T1 (de)	2011-07-15
US20100022603A1 (en)	2010-01-28

Similar Documents

Publication	Publication Date	Title
NO20092293L (no)	2009-09-08	Sulfonyl-fenyl-2H-[1,2,4]oksodiazol-5-onderivater, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytiske midler
NO20081367L (no)	2008-06-13	Fenyl- og pyridyl-1,2,4-oksadiazolonderivater med fenylgruppe, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytika
NO20081682L (no)	2008-05-06	4-oksy-N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika
NO20081681L (no)	2008-04-29	N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
TNSN08148A1 (en)	2009-07-14	Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
MX2007002689A (es)	2007-05-16	7-azaindoles y su uso como agonistas de ppar.
NO20091469L (no)	2009-04-15	Benzoxazoler og oxazolpyridiner anvendbare som Janus kinase inhibitorer
NO20076425L (no)	2008-01-30	Fremgangsmater for behandling av drug-resistent cancer
GEP20094725B (en)	2009-07-10	Process for production of optically active amine derivatives
TW200510352A (en)	2005-03-16	Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals
NO20054382L (no)	2005-09-21	Diarylsykloalkylderivater, deres fremstilling og deres anvendelse som legemiddel
TNSN06317A1 (en)	2007-12-03	Oxadiazolone derivatives as ppar delta agonists
TW200616985A (en)	2006-06-01	Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
KR20130110160A (ko)	2013-10-08	오렉신 수용체 안타고니스트로서의 프롤린 술폰아미드 유도체
TW200621732A (en)	2006-07-01	Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
NO20064982L (no)	2006-10-31	1,3,4-oksadiazol-2-oner som PPAR delta modulatorer og anvendelse derav
NO20081368L (no)	2008-06-18	Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika
TW200510399A (en)	2005-03-16	1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals
WO2007039174A3 (fr)	2007-08-09	[1,3,4]-thiadiazol-2-yl-amides bicycliques de l'acide aryl-sulfonique, leurs procedes de preparation, et leur utilisation en tant que substances pharmaceutiques
NO20063860L (no)	2006-08-29	7-fenylamino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav samt deres anvendelse som legemidler
TW200508229A (en)	2005-03-01	Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
TW200730516A (en)	2007-08-16	Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
TW200738654A (en)	2007-10-16	Alkoxymethyl-substituted benzoic acid derivatives, process for their preparation and their use as medicaments
TH88744B (th)	2008-02-29	ไบไซคลิคแอริล-ซัลโฟนิคแอซิด[1,3,4]-ไธอะไดแอโซล-2-อิล-แอมีด, กรรมวิธีสำหรับการเตรียมสารเหล่านั้นและการใช้สารเหล่านั้นเป็นสารเภสัชกรรม
TH99135B (th)	2009-11-25	อนุพันธ์ซัลโฟนิล-เฟนนิล-2h-[1,2,4]ออกซาไดอะโซล-5-โอนขบวนการเพื่อผลิตสารเหล่านี้และการใช้สารเหล่านี้ในทางเภสัชกรรม

Legal Events

Date	Code	Title	Description
2012-04-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application